Peripheral artery disease in chronic kidney disease: an underestimated comorbidity
Journal of Nephrology · 16.06.2026 · 39 (2) · 246-258
DOI: 10.1093/joneph/aajaf014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nephrology, online erschienen am 07.05.2026. Verfasst von Sidar Copur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Koc University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Renal Insufficiency, Chronic. Die Arbeit nennt 90 Literaturangaben.
Abstract (Originalsprache)
Chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m2 or the presence of clinical, imaging, or histopathological features of kidney injury over a 3-month period, has been linked to several comorbidities including cardiovascular diseases, such as myocardial infarction, cerebrovascular diseases, renal artery stenosis and peripheral artery disease. A pro-inflammatory and pro-fibrotic state, together with the accumulation of uremic toxins and impaired calcium-phosphorus homeostasis leading to mineral and bone disorders, appear to constitute the underlying pathophysiology of peripheral artery disease in CKD patients. Despite such association and the deleterious effects of peripheral artery disease, the association between CKD and peripheral artery disease is generally underestimated in clinical practice, with physicians being less likely to initiate pharmacotherapy or offer interventional treatments to patients with CKD. Many therapeutic options, including lifestyle modifications, methods for cardiovascular risk reduction such as anti-platelet or lipid-lowering drugs, targeted pharmacotherapies, and endovascular or surgical interventions are available for the management of peripheral artery disease. However, the diagnostic and/or therapeutic process in CKD patients is not as straightforward as it is in the general population, with misleading outcomes and higher treatment-related complications. Aim of this narrative review was to discuss the epidemiology, risk factors, underlying pathophysiology, and diagnostic and therapeutic approaches toward peripheral artery disease in CKD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
- Associazione Nefrologica Gabriella Sebastio, Martina Franca, Italy.
- Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Sidar Copur, Lasin Ozbek, Carlo Basile, Mehmet Kanbay
Zitieren
APA
Copur, S., Ozbek, L., Basile, C., & Kanbay, M. (2026). Peripheral artery disease in chronic kidney disease: an underestimated comorbidity. Journal of Nephrology, 39(2), 246-258. https://doi.org/10.1093/joneph/aajaf014
Vancouver
Copur S, Ozbek L, Basile C, Kanbay M. Peripheral artery disease in chronic kidney disease: an underestimated comorbidity. Journal of Nephrology. 2026;39(2):246-258. doi:10.1093/joneph/aajaf014
BibTeX
@article{Copur2026,
author = {Copur, Sidar and Ozbek, Lasin and Basile, Carlo and Kanbay, Mehmet},
title = {Peripheral artery disease in chronic kidney disease: an underestimated comorbidity},
journal = {Journal of Nephrology},
year = {2026},
volume = {39},
number = {2},
pages = {246--258},
doi = {10.1093/joneph/aajaf014}
}
EUVIMED